ROSELAND, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the Rodman and Renshaw 17th Annual Global Investment Conference at 9:35 AM ET on Wednesday, September 9, 2015. The Rodman and Renshaw conference is being held at The St. Regis Hotel in New York City.
Emisphere's presentation will be webcast live the day of the Rodman and Renshaw conference, and will be available on the company's website at http://ir.emisphere.com/events.cfm. An archive of the webcast will be available for 90 days following the day of the conference and can be accessed by following the same link.
Emisphere is a specialty pharmaceutical company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new, orally delivered therapeutics. For more information, please visit www.emisphere.com.
CONTACT: COMPANY CONTACTS: Alan L. Rubino, CEO 973.532.8000 firstname.lastname@example.org Michael R. Garone, CFO 973.532.8005 email@example.com INVESTOR CONTACTS: Susan Kim Argot Partners (212) 600-1902 firstname.lastname@example.org
Source:Emisphere Technologies, Inc.